The cyclotides: Novel macrocyclic peptides as scaffolds in drug design


Autoria(s): Craik, D. J.; Simonsen, S.; Daly, N. L.
Data(s)

12/03/2002

Resumo

Cyclotides are a novel class of circular, disulfide-rich peptides (similar to 30 amino acids) that display a broad range of bioactivities and have exceptionally high stability. Their physical properties, which include resistance to thermal and enzymatic degradation, can be attributed to their unique cyclic backbone and knotted arrangement of disulfide bonds. The applicability of linear peptides as drugs is potentially limited by their susceptibility to proteolytic cleavage and poor bioavailability. Such limitations may be overcome by using the cyclotide framework as a scaffold onto which new activities may be engineered. The potential use of cyclotides for drug design is evaluated here, with reference to rapidly increasing knowledge of natural cyclotides and the emergence of new techniques in peptide engineering.

Identificador

http://espace.library.uq.edu.au/view/UQ:62783

Idioma(s)

eng

Publicador

Current Drugs Ltd

Palavras-Chave #Pharmacology & Pharmacy #Circular Backbone #Cyclic Cystine Knot #Cyclotide #Peptide Engineering #Scaffold #Polypeptide Kalata B1 #Cystine-knot #Trypsin-inhibitor #Momordica-cochinchinensis #Membranolytic Selectivity #3-dimensional Structure #Antimicrobial Peptides #Chassalia-parvifolia #Oldenlandia-affinis #Plant Cyclotides #C1 #250302 Biological and Medical Chemistry #670403 Treatments (e.g. chemicals, antibiotics)
Tipo

Journal Article